mmm gwr says fas cant use voting power of these shares well i would say neither could gwr while they are in dispute hope meeting doesnt get postponed waiting for this to sort itself out
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
